USA - NYSE:SI - US82537J1088 - Common Stock
The current stock price of SI is 11.01 USD. In the past month the price decreased by -9.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.31 | 219.79B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.85 | 206.34B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.63 | 151.39B | ||
| SYK | STRYKER CORP | 27.05 | 136.22B | ||
| IDXX | IDEXX LABORATORIES INC | 56.58 | 57.08B | ||
| BDX | BECTON DICKINSON AND CO | 12.84 | 53.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.11 | 49.97B | ||
| RMD | RESMED INC | 25.46 | 36.79B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.07 | 33.67B | ||
| PODD | INSULET CORP | 71.49 | 23.00B | ||
| DXCM | DEXCOM INC | 31.12 | 22.70B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.84 | 17.37B |
Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
SHOULDER INNOVATIONS INC
1535 Steele Avenue SW, Suite B
Grand Rapids MICHIGAN 92037 US
CEO: Alan J. Lane
Employees: 61
Phone: 16162941026
Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
The current stock price of SI is 11.01 USD.
SI does not pay a dividend.
SI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
SHOULDER INNOVATIONS INC (SI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
SHOULDER INNOVATIONS INC (SI) will report earnings on 2025-11-11, after the market close.
You can find the ownership structure of SHOULDER INNOVATIONS INC (SI) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to SI.
ChartMill assigns a fundamental rating of 2 / 10 to SI. While SI seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SI reported a non-GAAP Earnings per Share(EPS) of -0.68. The EPS decreased by -50.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.59% | ||
| ROE | -28.22% | ||
| Debt/Equity | 0.35 |
13 analysts have analysed SI and the average price target is 19.99 USD. This implies a price increase of 81.58% is expected in the next year compared to the current price of 11.01.
For the next year, analysts expect an EPS growth of -249.58% and a revenue growth -77.48% for SI